| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 06/25/2014 | CN101680887B 测定脊柱侧凸风险的方法 Method for determining the risk of scoliosis |
| 06/24/2014 | US8759402 Method to inhibit ischemia and reperfusion injury |
| 06/24/2014 | US8759375 Methods for treating multiple myeloma using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione in combination with proteasome inhibitor |
| 06/24/2014 | US8759370 O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders |
| 06/24/2014 | US8759350 Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders |
| 06/24/2014 | US8759344 Imidazopyridine derivatives, process for preparation thereof and therapeutic use thereof |
| 06/24/2014 | US8759325 Compositions and methods of treatment for inflammatory diseases |
| 06/24/2014 | US8759310 Stabilized immune modulatory RNA (SIMRA) compounds for TLR7 and TLR8 |
| 06/24/2014 | US8759286 Pharmaceutical compositions comprising a VEGF-D polypeptide |
| 06/24/2014 | US8758824 Respirably dry powder comprising calcium lactate, sodium chloride and leucine |
| 06/24/2014 | US8758789 Medium chain peroxycarboxylic acid compositions |
| 06/24/2014 | US8758742 Prebiotic and preservative uses of oil emulsified probiotic encapsulations |
| 06/19/2014 | WO2014093918A1 Compositions and methods comprising polyethylene glycol and magnesium for treatment of neuronal injury |
| 06/19/2014 | WO2014093726A1 Methods of treating portal hypertension |
| 06/19/2014 | WO2014093711A1 Methods of treating hepatic fibrosis and associated diseases by regulating rev-erb activity |
| 06/19/2014 | WO2014093189A1 Methods of treating diabetes by administering a glucagon receptor antagonist in combination with a cholesterol absorption inhibitor |
| 06/19/2014 | WO2014092905A1 Methods and assays for combination treatment of cancer |
| 06/19/2014 | WO2014092154A1 Prevention or treatment agent for hepatic fibrosis |
| 06/19/2014 | WO2014092007A1 Hair growing agent |
| 06/19/2014 | WO2014092006A1 Novel octahydropyridoquinazoline derivative, pharmaceutical composition containing same, and uses for said derivative and composition |
| 06/19/2014 | WO2014091388A2 Biomarker predictive of responsiveness to alpha 7 nicotinic acetylcholine receptor activator treatment |
| 06/19/2014 | WO2014091138A1 Chitin or derivatives thereof for the prevention and/or treatment of parasitoses |
| 06/19/2014 | WO2014090875A1 Combination of ethambutol with at least one additional anti-bacterial agent for use in the treatment of bacterial infections |
| 06/19/2014 | WO2014090586A1 Delphinidin for combating melanoma cells |
| 06/19/2014 | WO2014090583A1 Delphinidin for combating melanoma cells |
| 06/19/2014 | WO2014064191A3 Drug combinations containing statins for treating cardiovascular diseases |
| 06/19/2014 | WO2013158814A8 Immediate release, abuse deterrent pharmaceutical compositions |
| 06/19/2014 | US20140171472 Pyridoxamine for the Treatment of Diabetic Kidney Disease |
| 06/19/2014 | US20140171448 Use of nicotinic acetylcholine receptor alpha 7 activators |
| 06/19/2014 | US20140171447 Chloro-pyrazine carboxamide derivatives with epithelial sodium channel blocking activity |
| 06/19/2014 | US20140171445 Treatment and prevention of diseases mediated by microorganisms via drug-mediated manipulation of the eicosanoid balance |
| 06/19/2014 | US20140171444 Inhibitors of Mycobacterium Tuberculosis Malate Synthase, Methods of Making and Uses Thereof |
| 06/19/2014 | US20140171439 Inhibitors Of Histone Deacetylase |
| 06/19/2014 | US20140171435 Chemical Compounds |
| 06/19/2014 | US20140171434 Substituted imidazopyridines and imidazopyridazines and the use thereof |
| 06/19/2014 | US20140171431 Azole heterocyclic compound, preparation method, pharmaceutical composition and use |
| 06/19/2014 | US20140171420 Diazole lactams |
| 06/19/2014 | US20140171417 Tricyclic compounds |
| 06/19/2014 | US20140171412 Tricyclic compounds |
| 06/19/2014 | US20140171411 (THIENO[2,3-b][1,5]BENZOXAZEPIN-4-YL)PIPERAZIN-1-YL COMPOUNDS AS DUAL ACTIVITY H1 INVERSE AGONISTS/5-HT2A ANTAGONISTS |
| 06/19/2014 | US20140171407 1,7-diazacarbazoles and methods of use |
| 06/19/2014 | US20140171404 Autotaxin inhibitors |
| 06/19/2014 | US20140171398 Formoterol/steroid bronchodilating compositions and methods of use thereof |
| 06/19/2014 | US20140171397 Biphenyl compounds useful as muscarinic receptor antagonists |
| 06/19/2014 | US20140171390 Beta-lactamase inhibitors |
| 06/19/2014 | US20140171389 Methods for treating cancer |
| 06/19/2014 | US20140171387 Compound having detrusor muscle-contracting activity and urethral sphincter muscle-relaxing activity |
| 06/19/2014 | US20140171382 Methods for identifying an increased risk of anthracycline-related cardiotoxicity |
| 06/19/2014 | US20140171363 Bicyclic acetyl-coa carboxylase inhibitors and uses thereof |
| 06/19/2014 | US20140171358 Antimicrobial compositions comprising dgla and neomycin sulfate and methods of use thereof |
| 06/19/2014 | US20140170244 3,5-diamino-6-chloro-n-(n-(4-phenylbutyl)carbamimidoyl) pyrazine-2- carboxamide compounds |
| 06/19/2014 | US20140170243 Substituted chroman derivatives, medicaments and use in therapy |
| 06/19/2014 | US20140170216 Bupropion hydrobromide polymorphs |
| 06/19/2014 | US20140170210 Methods for treating immunosuppression |
| 06/19/2014 | US20140170206 Composition for the transdermal delivery of fentanyl |
| 06/19/2014 | US20140170156 Human monoclonal antibodies against interleukin 8 (il-8) |
| 06/19/2014 | US20140170155 Method for Treating a GD2 Positive Cancer |
| 06/19/2014 | US20140170152 Immunobinders directed against tnf |
| 06/19/2014 | US20140170148 Bispecific antibodies against her2 |
| 06/19/2014 | US20140170141 Polypeptides and uses thereof for treatment of autoimmune disorders and infection |
| 06/19/2014 | US20140170140 Compositions and methods for the treatment of neuromyelitis optica |
| 06/19/2014 | US20140170134 Compositions and methods related to antibodies to staphylococcal protein a |
| 06/19/2014 | US20140170111 Fused tetracycle derivatives and methods of use thereof for the treatment of viral diseases |
| 06/19/2014 | US20140170110 Pyridin-2(1h)-one derivatives useful as medicaments for the treatment of myeloproliferative disorders, transplant rejection, immune-mediated and inflammatory diseases |
| 06/19/2014 | US20140170108 Compositions useful for the treatment of inflammatory disease or disorders |
| 06/19/2014 | US20140170063 Dosages of Immunoconjugates of Antibodies and SN-38 for Improved Efficacy and Decreased Toxicity |
| 06/18/2014 | EP2742953A1 Therapeutic agent for autoimmune diseases comprising pd-1 agonist |
| 06/18/2014 | EP2742937A1 Compositions for use in the treatment of bacterial infections |
| 06/18/2014 | EP2741748A1 Beta-lactam compounds for enhancing t cell-mediated immune responses |
| 06/18/2014 | CN103861112A Pharmaceutical composition based on polymer nanoparticle carrier and preparation method thereof |
| 06/18/2014 | CN103861107A Pharmaceutical composition and uses thereof |
| 06/18/2014 | CN103861106A Antagonists of IL-6 to raise albumin and/or lower CRP |
| 06/18/2014 | CN103861105A Compound preparation comprising traditional Chinese medicine pseudo-ginseng and lipid-lowering drug statins and its preparation method |
| 06/18/2014 | CN102988987B Pharmaceutical composition for treating hyperproliferative skin disease and preparation of pharmaceutical composition |
| 06/18/2014 | CN102821754B Multilayer melt-extruded film |
| 06/18/2014 | CN102813924B Drug combination product for analgesia based on sinomenine |
| 06/18/2014 | CN102731405B Photodynamic treatment medicament, medical composition and preparation method thereof |
| 06/18/2014 | CN102526079B Sphingosine-1-phosphate receptor agonists in the treatment of demyelinating disorders |
| 06/18/2014 | CN102271711B Immunological reconstitution promoter or prophylactic agent for infections each of which maintains graft-versus-tumor effect |
| 06/18/2014 | CN102049050B Anti-herpesvirus infection medicinal composition |
| 06/18/2014 | CN101932320B Membrane fusion inhibitor |
| 06/18/2014 | CN101897696B Sugar-lowering drug composition and application thereof |
| 06/18/2014 | CN101890018B Tyrosine protein kinase inhibitor and preparation method thereof |
| 06/18/2014 | CN101288659B Floating type pellets in stomach and preparation method thereof |
| 06/17/2014 | US8754102 Nitrogen containing compounds and their use |
| 06/17/2014 | US8754063 Use of oligouronates for treating mucus hyperviscosity |
| 06/17/2014 | US8754046 MHC class II restricted T cell epitopes from the cancer anitgen, NY ESO-1 |
| 06/17/2014 | US8753833 Copolymer assay |
| 06/17/2014 | US8753697 Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals |
| 06/17/2014 | US8753671 Filament based on hyaluronic acid in the form of free acid and method for obtaining it |
| 06/17/2014 | US8753651 Capsular polysaccharide solubilisation and combination vaccines |
| 06/17/2014 | US8753621 BAB triblock polymers having improved release characteristics |
| 06/17/2014 | US8753618 Method, composition and package for bowel cleansing |
| 06/17/2014 | US8753604 Methods and compositions for synaphically-targeted treatment for cancer |
| 06/17/2014 | CA2659599C Amino alcohol derivative and immunosuppressive agent having same as an active ingredient |
| 06/17/2014 | CA2604617C Composition containing anti-dementia drug |
| 06/17/2014 | CA2584806C Treatment of obesity and related disorders |
| 06/17/2014 | CA2535063C Medicament preparations for transdermal application containing active ingredient combinations for treating parkinson's disease |
| 06/17/2014 | CA2505469C Drug delivery device comprising a bilayered polymeric coating having a cell cycle inhibitor that acts selectively at the g1 phase of the cell cycle incorporated into the first polymer coating layer |
| 06/17/2014 | CA2370306C Treatment of fibrosis by antagonism of il-13 and il-13 receptor chains |